Advertisement

U.S. Markets open in 1 hr 4 mins

S&P Futures
5,879.25
-13.25(-0.22%)
Dow Futures
42,960.00
-209.00(-0.48%)
Nasdaq Futures
20,479.50
-62.50(-0.30%)
Russell 2000 Futures
2,237.00
-9.20(-0.41%)
Crude Oil
70.47
-1.27(-1.77%)
Gold
2,761.90
+2.10(+0.08%)

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

7.65

-0.14

(-1.80%)

At close: 04:00PM EDT

7.28

-0.37

(-4.84%)

After hours:

06:24PM EDT

Loading interactive chart...

Zacks
Sage Therapeutics, Inc. (SAGE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Sage Therapeutics (SAGE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GuruFocus.com
State Street Corp's Strategic Acquisition of Sage Therapeutics Shares
On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 451,377 shares of Sage Therapeutics Inc (NASDAQ:SAGE) at a price of $7.22 per share. This transaction increased State Street Corp's total holdings in Sage Therapeutics to 2,926,239 shares, marking a notable expansion in their investment in the biotechnology sector. State Street Corp, headquartered at One Lincoln Street, Boston, MA, is a prominent financial services provider known for its robust investment strategies.